Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication
- PMID: 9628929
- PMCID: PMC147669
- DOI: 10.1093/nar/26.13.3270
Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication
Abstract
Retroviral vectors were engineered to express either sense (MoTiN-TRPsie+) or sense and antisense (MoTN-TRPsie+/-) RNAs containing the human immunodeficiency virus type-1 (HIV-1) trans -activation response (TAR) element and the extended packaging (Psie) signal. The Psie signal includes the dimer linkage structure (DLS) and the Rev response element (RRE). Amphotropic vector particles were used to transduce a human CD4+ T-lymphoid (MT4) cell line. Stable transductants were then tested for sense and antisense RNA production and susceptibility to HIV-1 infection. HIV-1 production was significantly decreased in cells transduced with MoTiN-TRPsie+ and MoTN-TRPsie+/-vectors. Efficient packaging of sense and most remarkably of antisense RNA was observed within the virus progeny. Infectivity of this virus was significantly decreased in both cases, suggesting that the interfering RNAs were co-packaged with HIV-1 RNA. Vector transduction was not expected to occur and was not observed. Inhibition of HIV-1 replication was also demonstrated in human peripheral blood lymphocytes transduced with retroviral vectors expressing antisense RNA. These results suggest that (i) both sense and antisense RNAs were co-packaged with HIV-1 RNA, (ii) the co-packaged sense and antisense RNAs inhibited virus infectivity and (iii) the co-packaged sense and antisense RNAs were not transduced. Sense and antisense RNA-based strategies may also be used to co-package other interfering RNAs (e.g. ribozymes) to cleave HIV-1 virion RNA.
Similar articles
-
A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.Front Biosci. 2002 Feb 1;7:a15-28. doi: 10.2741/ding. Front Biosci. 2002. PMID: 11815282
-
Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).Antisense Res Dev. 1994 Spring;4(1):19-26. doi: 10.1089/ard.1994.4.19. Antisense Res Dev. 1994. PMID: 7914762
-
Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.J Virol. 1998 Mar;72(3):1894-901. doi: 10.1128/JVI.72.3.1894-1901.1998. J Virol. 1998. PMID: 9499041 Free PMC article.
-
Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.Curr HIV Res. 2004 Apr;2(2):185-91. doi: 10.2174/1570162043484906. Curr HIV Res. 2004. PMID: 15078182 Review.
-
Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies.Front Biosci. 2000 May 1;5:D527-55. doi: 10.2741/lamothe. Front Biosci. 2000. PMID: 10799355 Review.
Cited by
-
An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication.J Virol. 1999 Sep;73(9):7671-7. doi: 10.1128/JVI.73.9.7671-7677.1999. J Virol. 1999. PMID: 10438857 Free PMC article.
-
Molecular strategies to inhibit HIV-1 replication.Retrovirology. 2005 Feb 16;2:10. doi: 10.1186/1742-4690-2-10. Retrovirology. 2005. PMID: 15715913 Free PMC article. Review.
-
HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.J Gene Med. 2006 Jan;8(1):18-28. doi: 10.1002/jgm.825. J Gene Med. 2006. PMID: 16142830 Free PMC article.
-
Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.Clin Exp Immunol. 2005 Jul;141(1):72-80. doi: 10.1111/j.1365-2249.2005.02826.x. Clin Exp Immunol. 2005. PMID: 15958072 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials